Molecular events in primary and metastatic colorectal carcinoma: a review.

Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int. 2012;2012:597497 Authors: Kanthan R, Senger JL, Kanthan SC Abstract Colorectal cancer (CRC) is a heterogeneous disease, developing through a multipathway sequence of events guided by clonal selections. Pathways included in the development of CRC may be broadly categorized into (a) genomic instability, including chromosomal instability (CIN), microsatellite instability (MSI), and CpG island methylator phenotype (CIMP), (b) genomic mutations including suppression of tumour suppressor genes and activation of tumour oncogenes, (c) microRNA, and (d) epigenetic changes. As cancer becomes more advanced, invasion and metastases are facilitated through the epithelial-mesenchymal transition (EMT), with additional genetic alterations. Despite ongoing identification of genetic and epigenetic markers and the understanding of alternative pathways involved in the development and progression of this disease, CRC remains the second highest cause of malignancy-related mortality in Canada. The molecular events that underlie the tumorigenesis of primary and metastatic colorectal carcinoma are detailed in this manuscript. PMID: 22997602 [PubMed]
Source: Pathology Research International - Category: Pathology Tags: Patholog Res Int Source Type: research